Quoin Pharmaceuticals Ltd ADR [NASDAQ: QNRX] price surged by 3.39 percent to reach at $0.02.
The one-year QNRX stock forecast points to a potential upside of 93.11. The average equity rating for QNRX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Quoin Pharmaceuticals Ltd ADR [QNRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for QNRX shares is $4.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on QNRX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Quoin Pharmaceuticals Ltd ADR is set at 0.08 The Price to Book ratio for the last quarter was 0.28, with the Price to Cash per share for the same quarter was set at 2.04.
QNRX Stock Performance Analysis:
Quoin Pharmaceuticals Ltd ADR [QNRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.69. With this latest performance, QNRX shares dropped by -54.58% in over the last four-week period, additionally sinking by -48.26% over the last 6 months – not to mention a drop of -91.16% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for QNRX stock in for the last two-week period is set at 31.42, with the RSI for the last a single of trading hit 28.34, and the three-weeks RSI is set at 34.75 for Quoin Pharmaceuticals Ltd ADR [QNRX]. The present Moving Average for the last 50 days of trading for this stock 0.5843, while it was recorded at 0.3064 for the last single week of trading, and 0.6338 for the last 200 days.
Insight into Quoin Pharmaceuticals Ltd ADR Fundamentals:
Quoin Pharmaceuticals Ltd ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.02 and a Current Ratio set at 3.02.
Quoin Pharmaceuticals Ltd ADR [QNRX] Institutonal Ownership Details
There are presently around $5.89%, or 6.03%% of QNRX stock, in the hands of institutional investors.
